|
KDM5B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.294200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.877200E-01 |
| Normal-vs-Stage2 |
1.284210E-01 |
| Normal-vs-Stage3 |
2.594600E-01 |
| Normal-vs-Stage4 |
1.739000E-01 |
| Stage1-vs-Stage2 |
1.790270E-02 |
| Stage1-vs-Stage3 |
7.575000E-01 |
| Stage1-vs-Stage4 |
5.774200E-01 |
| Stage2-vs-Stage3 |
2.077700E-02 |
| Stage2-vs-Stage4 |
9.719900E-03 |
| Stage3-vs-Stage4 |
7.782200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.629010E-01 |
| Normal-vs-AfricanAmerican |
3.313900E-02 |
| Normal-vs-Asian |
4.020000E-01 |
| Caucasian-vs-AfricanAmerican |
6.896000E-02 |
| Caucasian-vs-Asian |
8.640800E-01 |
| AfricanAmerican-vs-Asian |
9.421900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.334800E-01 |
| Normal-vs-Female |
3.392400E-01 |
| Male-vs-Female |
9.656800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.355570E-01 |
| Normal-vs-Age(41-60Yrs) |
5.104800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.115200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.540200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.965600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.893810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.408200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.086000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.970400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.735600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.923400E-01 |
| Classical-VS-Follicular |
1.6251444634463E-12 |
| Classical-VS-Other |
2.528200E-01 |
| Classical-VS-Normal |
5.582400E-03 |
| Tall-VS-Follicular |
1.57594999999899E-05 |
| Tall-VS-Other |
4.242000E-01 |
| Tall-VS-Normal |
2.000000E-01 |
| Follicular-VS-Other |
1.131580E-01 |
| Follicular-VS-Normal |
9.76089999999985E-05 |
| Other-VS-Normal |
8.373400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.562600E-01 |
| Normal-vs-N1 |
3.467200E-01 |
| N0-vs-N1 |
6.822200E-02 |
|
|
